Equities

GMO Research & AI Inc

GMORF:PNK

GMO Research & AI Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments885767665
Total Receivables, Net8791,053867
Total Inventory606341
Prepaid expenses189190165
Other current assets, total473523620
Total current assets2,4852,5962,358
Property, plant & equipment, net232932
Goodwill, net------
Intangibles, net245198185
Long term investments1059880
Note receivable - long term------
Other long term assets373633
Total assets2,9943,0722,800
LIABILITIES
Accounts payable229260242
Accrued expenses149196154
Notes payable/short-term debt000
Current portion long-term debt/capital leases7.899.127.57
Other current liabilities, total546684705
Total current liabilities9321,1491,108
Total long term debt4.337.6812
Total debt121719
Deferred income tax------
Minority interest0.21----
Other liabilities, total107.033.82
Total liabilities9461,1631,123
SHAREHOLDERS EQUITY
Common stock299299299
Additional paid-in capital392393393
Retained earnings (accumulated deficit)1,3801,2511,032
Treasury stock - common(46)(47)(48)
Unrealized gain (loss)5.614.830.21
Other equity, total157.760.07
Total equity2,0471,9091,677
Total liabilities & shareholders' equity2,9943,0722,800
Total common shares outstanding1.631.631.63
Treasury shares - common primary issue0.040.040.05
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.